Consolidated Balance Sheet

K Pharma,Inc. - Filing #7311570

Concept As at
2024-06-30
As at
2023-12-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
4,934,000 JPY
4,934,000 JPY
Investments and other assets
4,934,000 JPY
4,934,000 JPY
Current assets
Cash and deposits
2,694,656,000 JPY
3,266,408,000 JPY
Prepaid expenses
48,440,000 JPY
31,374,000 JPY
Raw materials and supplies
6,765,000 JPY
10,794,000 JPY
Other
34,470,000 JPY
391,000 JPY
Current assets
2,784,332,000 JPY
3,308,968,000 JPY
Non-current assets
Investments and other assets
Assets
2,789,266,000 JPY
3,313,902,000 JPY
Liabilities
Current liabilities
Deposits received
4,015,000 JPY
JPY
Accounts payable - other
JPY
7,271,000 JPY
Income taxes payable
1,155,000 JPY
69,583,000 JPY
Accrued expenses
62,643,000 JPY
30,116,000 JPY
Other
JPY
59,714,000 JPY
Current liabilities
79,705,000 JPY
178,480,000 JPY
Non-current liabilities
Non-current liabilities
31,298,000 JPY
30,654,000 JPY
Asset retirement obligations
31,298,000 JPY
30,654,000 JPY
Liabilities
111,003,000 JPY
209,134,000 JPY
Liabilities and net assets
Shareholders' equity
2,678,263,000 JPY
3,104,768,000 JPY
Share capital
100,000,000 JPY
854,087,000 JPY
Capital surplus
3,004,768,000 JPY
3,003,337,000 JPY
Retained earnings
-426,505,000 JPY
-752,656,000 JPY
Net assets
2,678,263,000 JPY
3,104,768,000 JPY
Liabilities and net assets
2,789,266,000 JPY
3,313,902,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.